Meropenem

Half-Life (t½)
IV: 1h
Formula
C17H25N3O5S
Molecular Weight
437.52 g/mol
PubChem CID
441130
Aliases
Merrem

Pharmacological Mechanism

Carbapenem β-lactam — very broad spectrum (gram-positive, gram-negative including Pseudomonas + ESBL producers, anaerobes). Reserved for severe infections + ESBL-producing organisms. Lower seizure risk than imipenem.

Half-Life & Elimination Curve (IV: 1h)

100%50%25%12.5%0%0h0×t½1h1×t½2h2×t½3h3×t½4h4×t½5h5×t½0×t½ (0h): 100% remaining (~49 mg/L)1×t½ (1h): 50% remaining (~24.5 mg/L)2×t½ (2h): 25% remaining (~12.3 mg/L)3×t½ (3h): 12.5% remaining (~6.13 mg/L)4×t½ (4h): 6.3% remaining (~3.06 mg/L)5×t½ (5h): 3.1% remaining (~1.53 mg/L)
Elimination (IV)
  • 0×t½0h100% (49 mg/L)
  • 1×t½1h50% (24.5 mg/L)
  • 2×t½2h25% (12.3 mg/L)
  • 3×t½3h12.5% (6.13 mg/L)
  • 4×t½4h6.3% (3.06 mg/L)
  • 5×t½5h3.1% (1.53 mg/L)
Elimination t½1h (IV)
Rate Constant (ke)0.693 h⁻¹
Est. Peak (Cmax)49 mg/L
Clearance (CL)14.1 L/h
97% Washout (5×t½)5h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References